Microfluidic platforms, such as labchip, are widely used for assessing wild type capsids. Now, engineered capsids are challenging these established workflows.
- Why Pharmaceutical And Medical Device Risks Must Be Analyzed By Their Risk Mechanisms
- NanoCell's Moonshot Aims To Unlock In Vivo Cell Therapy
- The Regulatory Imperative To Improve Environmental And Sustainability Stewardship In Biopharma
- How You And Your CDMO Should Leverage Contamination Control Strategies For Competitive Advantage
- Leveraging AI And Data Science For Biologics Characterization
- Operating And Maintaining Pharmaceutical Gas Distribution Systems
- The Death Of A Dogma: David Baltimore And Lessons For Modern Drug Discovery
- August 2025 — CDMO Opportunities And Threats Report
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![GettyImages-1807380819-scientist-laboratory-equipment-research]( "N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit")
N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy RetrofitDiscover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.
-
![Corning Ascent FBR]( "Highly Efficient Production Of Adeno-Associated Virus")
Highly Efficient Production Of Adeno-Associated VirusThis study evaluates the performance of a flexible, automated fixed bed reactor (FBR) system during AAV production, comparing it with a similar FBR system and 2D cell culture controls.
-
![GettyImages-1219551222-Patient-Person-Recruitment-Select]( "Data-Driven Physician Engagement For Ultra-Rare Diseases")
Data-Driven Physician Engagement For Ultra-Rare DiseasesHow can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?
-
![Eppendorf - Bioflo control station]( "Large-Scale Exosome Production Stirred-Tank Bioreactors")
Large-Scale Exosome Production Stirred-Tank BioreactorsDiscover how engineered exosomes, displaying tumor-homing peptides, offer a promising tool for targeted cytotoxic drug delivery, produced efficiently with a bioreactor for critical research.
-
![COVID GettyImages-1372859699]( "Infectious Diseases – 2018-2023 Global Clinical Trial Landscape")
Infectious Diseases – 2018-2023 Global Clinical Trial LandscapeGain in-depth insights into infectious diseases-based clinical trials and be better informed about trends, regional disparities, technological advancements, and financing dynamics.
-
![Scientist with DNA copying PCR cycler GettyImages-177381768]( "Performance Comparison Of The Vericheck ddPCR™ Empty-Full Capsid Kit And Analytical Ultracentrifugation (AUC)")
Performance Comparison Of The Vericheck ddPCR™ Empty-Full Capsid Kit And Analytical Ultracentrifugation (AUC)Discover how Droplet Digital PCR (ddPCR) offers a precise analysis of AAV capsid content, outperforming analytical ultracentrifugation (AUC) in distinguishing therapeutic genomes from contaminants.
-
![GettyImages-2160715445-female-scientist-computer-lab-coat]( "Automating High-Throughput Screens Using Patient-Derived Organoids")
Automating High-Throughput Screens Using Patient-Derived OrganoidsMany oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
![Getty Images-823447656-vector-viral-lab-AAV-cell-development]( "Exploring The Future Of Viral Vector Development And Production")
Exploring The Future Of Viral Vector Development And ProductionThe demand for viral vectors continues to grow, making addressing the challenges related to their manufacturing and scale-up increasingly critical.
-
![Stem-cell-allogeneic-iStock-629606180]( "Cell Culture Process Scale-Up Challenges For Commercial-Scale PSC Manufacturing")
Cell Culture Process Scale-Up Challenges For Commercial-Scale PSC ManufacturingAllogeneic cell therapies offer incredible promise, but scaling up PSC manufacturing presents unique challenges. Explore these hurdles along with solutions for consistent, high-quality production.
NEWSLETTER ARCHIVE
- 09.18.25 -- Contract Manufacturing Outsourcing Trends For Advanced Therapies In 2025 And Beyond
- 09.17.25 -- Building Modularity Into Your Biopharmaceutical Production
- 09.17.25 -- Developing Interleukin-2 For Cell Therapies: Key Considerations
- 09.16.25 -- Reimagining the future of aseptic filling
- 09.16.25 -- STREAM Edition: Developing CRISPR-GPT, An AI-Driven Multi-Agent System
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
